FDA Determines Regulatory Review Period for MACROPLASTIQUE IMPLANTS Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for MACROPLASTIQUE IMPLANTS, a medical device, in order to extend its patent protection as required by law.